[1]
“The 6-month drug survival rate in patients with rheumatoid arthritis treated with tofacitinib”, Ann Med Res , vol. 28, no. 7, pp. 1332–1335, Jul. 2021, Accessed: Apr. 26, 2025. [Online]. Available: http://annalsmedres.org/index.php/aomr/article/view/3844